We are switching from Ozempic to Wegovy because Wegovy is a better fit for the treatment we offer: support with weight loss and weight management.
Ozempic and Wegovy contain the same active ingredient: semaglutide. Your body is therefore already familiar with this substance. The main difference is what the medication is officially intended for. Ozempic was primarily developed for the treatment of diabetes, while Wegovy is specifically registered for weight loss and weight management. That is why Wegovy also aligns better with the goal of your treatment.
What does this mean for you?
The active ingredient remains the same: Wegovy contains, just like Ozempic, semaglutide.
The treatment remains focused on weight loss: Wegovy is specifically intended for this purpose.
More room to build up the treatment: Wegovy can be used in higher dosages than Ozempic. This allows the treatment to be better tailored to your progress and goals.
The switch is medically more logical and future-proof: because Wegovy is a better fit for weight management, we will focus our offering on this.
Ozempic is being phased out: Ozempic will no longer be available to order through us in the future.
You will receive clear instructions: if the switch applies to you, you will receive information about this by email.
Why is this switch important?
With this change, we ensure that your treatment better aligns with the goal for which you are using it: responsible and sustainable weight loss. Wegovy offers more possibilities for this than Ozempic, while the active ingredient remains the same. This way, we can make the treatment clearer, more suitable, and more future-proof for you.
More information about Wegovy? View all articles about Wegovy here.
Do you still have questions? Please contact us by sending an email to [email protected].